Biotech Target N V - 06 Jan 2022 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role: 10%+ Owner
Signature: /s/ Ivo Betschart
Issuer symbol: MTEM
Transactions as of: 06 Jan 2022
Transactions value $: $807,180
Form type: 4
Date filed: 10 Jan 2022, 10:49
Previous filing: 07 Jan 2022
Next filing: 18 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTEM	Common Stock	Purchase	$807K	+200K	+1.85%	$4.04^*	11M	06 Jan 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.